Clinical and pathological effects of the magnetic resonance imaging contrast agent gadodiamide on a new, adenine-sensitized, rat model of nephrogenic systemic fibrosis

被引：0
|
作者：
Fretellier, N. [1 ]
Bouzian, N. [1 ]
Bruneval, P. [2 ]
Daubine, F. [3 ]
Parmentier, N. [1 ]
Idee, J. [1 ]
Corot, C. [1 ]
机构：
[1] Div Res, Guerbet, Roissy CDG, France
[2] Univ Paris 05, Paris, France
[3] Atlantic Bone Screen, Nantes, France
来源：
TOXICOLOGY LETTERS | 2011年 / 205卷
关键词：
D O I：
10.1016/j.toxlet.2011.05.634
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 31 条
  • [1] Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
    Marckmann, Peter
    Skov, Lone
    Rossen, Kristian
    Dupont, Anders
    Damholt, Mette Brimnes
    Heaf, James Goya
    Thomsen, Henrik S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09): : 2359 - 2362
  • [2] Nephrogenic Systemic Fibrosis-Like Effects of Magnetic Resonance Imaging Contrast Agents in Rats with Adenine-Induced Renal Failure
    Fretellier, Nathalie
    Bouzian, Nejma
    Parmentier, Nadge
    Bruneval, Patrick
    Jestin, Gaelle
    Factor, Cecile
    Mandet, Chantal
    Daubine, Florence
    Massicot, France
    Laprevote, Olivier
    Hollenbeck, Claire
    Port, Marc
    Idee, Jean-Marc
    Corot, Claire
    TOXICOLOGICAL SCIENCES, 2013, 131 (01) : 259 - 270
  • [3] High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent
    Rydahl, Casper
    Thomsen, Henrik S.
    Marckmann, Peter
    INVESTIGATIVE RADIOLOGY, 2008, 43 (02) : 141 - 144
  • [4] Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis
    Bhave, Gautam
    Lewis, Julia B.
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2008, 180 (03): : 830 - 835
  • [5] GADODIAMIDE INJECTION - 2 NEW MAGNETIC-RESONANCE-IMAGING CONTRAST AGENT - INTRODUCTION
    HASSO, AN
    SZE, G
    INVESTIGATIVE RADIOLOGY, 1993, 28 : S2 - S2
  • [6] Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis - Comment
    Weiss, Robert E.
    Kennedy, Eugene C.
    JOURNAL OF UROLOGY, 2008, 180 (03): : 835 - 835
  • [7] PRECLINICAL SAFETY ASSESSMENT AND PHARMACOKINETICS OF GADODIAMIDE INJECTION, A NEW MAGNETIC-RESONANCE-IMAGING CONTRAST AGENT
    HARPUR, ES
    WORAH, D
    HALS, PA
    HOLTZ, E
    FURUHAMA, K
    NOMURA, H
    INVESTIGATIVE RADIOLOGY, 1993, 28 : S28 - S43
  • [8] Nephrogenic Systemic Fibrosis-like Effects of Magnetic Resonance Imaging Contrast Agents in Rats With Adenine-Induced Renal Failure (vol 131, pg 259, 2013)
    Fretellier, Nathalie
    Bouzian, Nejma
    Parmentier, Nadege
    Bruneval, Patrick
    Jestin, Gaelle
    Factor, Cecile
    Mandet, Chantal
    Daubine, Florence
    Massicot, France
    Laprevote, Olivier
    Hollenbeck, Claire
    Port, Marc
    Idee, Jean-Marc
    Corot, Claire
    TOXICOLOGICAL SCIENCES, 2013, 132 (01) : 252 - 252
  • [9] Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: A case-control study
    Kallen, AlexanderJ.
    Jhung, MichaelA.
    Cheng, Steven
    Hess, Theresa
    Turabelidze, George
    Abramova, Liana
    Arduino, Matthew
    Guarner, Jeannette
    Pollack, Brian
    Saab, Georges
    Patel, Priti R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (06) : 966 - 975
  • [10] Nephrogenic systemic fibrosis as an adverse drug reaction of gadolinium-based contrast media for magnetic resonance imaging
    Giersig, C.
    RADIOLOGE, 2007, 47 (09): : 794 - 799
1234